| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Mar 15, 2025 | Mar 18, 2025 | DAVITA INC. | CFO | Sell | 45.0 | -429 | -0.30% | ✗ | $921.5K |
| Sep 16, 2024 | Sep 17, 2024 | DAVITA INC. | CFO | Sell | 36.3 | -58,286 | -31.38% | ✗ | $9.5M |
| Aug 27, 2024 | Aug 29, 2024 | DAVITA INC. | CFO | Sell | 15.0 | -68,769 | -39.18% | ✗ | $10.7M |
| Mar 14, 2024 | Mar 18, 2024 | DAVITA INC. | CFO | Sell | 100.0 | +18,707 | 11.93% | ✗ | $1.1M |
| Mar 6, 2024 | Mar 8, 2024 | DAVITA INC. | CFO | Sell | 36.3 | -38,557 | -19.74% | ✗ | $5.2M |
| Feb 21, 2024 | Feb 23, 2024 | DAVITA INC. | CFO | Sell | 37.5 | -38,366 | -21.47% | ✗ | $4.7M |
| May 15, 2023 | May 17, 2023 | DAVITA INC. | CFO | Sell | 37.5 | -20,486 | -14.21% | ✗ | $2M |
| May 10, 2023 | May 12, 2023 | DAVITA INC. | CFO | Sell | 37.5 | -46,885 | -24.53% | ✗ | $4.7M |
| Mar 15, 2023 | Mar 17, 2023 | DAVITA INC. | CFO | Sell | 97.5 | +18,703 | 16.51% | ✗ | $377.8K |
| May 15, 2022 | May 17, 2022 | DAVITA INC. | CFO | Sell | 37.5 | -33,995 | -29.52% | ✗ | $3.4M |
| Aug 9, 2021 | Aug 11, 2021 | DAVITA INC. | CFO | Sell | 35.0 | -112,319 | -62.17% | ✗ | $15M |
| Aug 5, 2021 | Aug 6, 2021 | DAVITA INC. | CFO | Sell | 17.5 | -37,760 | -51.54% | ✗ | $5M |
| May 15, 2021 | May 18, 2021 | DAVITA INC. | CFO | Sell | 37.5 | -24,339 | -24.94% | ✗ | $3.1M |
| Dec 19, 2020 | Dec 21, 2020 | DAVITA INC. | CFO | Sell | 40.0 | -4,890 | -8.37% | ✗ | $564.1K |
| May 15, 2020 | May 19, 2020 | DAVITA INC. | CFO | Sell | 78.8 | +691 | 1.20% | ✗ | $33.7K |
| Oct 12, 2018 | Oct 12, 2018 | CHAMPIONS ONCOLOGY, INC. | Director | Sell | 22.5 | -12,021 | -1.07% | ✗ | $210K |
| Oct 1, 2018 | Oct 3, 2018 | CHAMPIONS ONCOLOGY, INC. | Director | Sell | 20.0 | -22,535 | -2.16% | ✗ | $383.5K |
| Oct 18, 2016 | Oct 20, 2016 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 55.0 | +2,000 | 0.19% | ✗ | $3.4K |
| Oct 13, 2016 | Oct 14, 2016 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 68.8 | +7,300 | 0.71% | ✗ | $12.2K |
| Oct 6, 2016 | Oct 7, 2016 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 68.8 | +8,202 | 0.80% | ✗ | $13.4K |
| Sep 23, 2016 | Sep 26, 2016 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 47.5 | +33 | 0.00% | ✗ | $54.5 |
| Sep 20, 2016 | Sep 21, 2016 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 60.0 | +5,000 | 0.49% | ✗ | $8.3K |
| Jan 28, 2013 | Jan 30, 2013 | CHAMPIONS ONCOLOGY, INC. | CEO | Buy | 97.5 | +528,315 | 158.49% | ✗ | $250K |